Hua Xia Shi Bao·2025-09-26 12:20Company Overview - Tigermed (stock code: 300347.SZ/3347.HK) is an integrated biopharmaceutical research and development service platform providing one-stop innovative R&D services and solutions for the global pharmaceutical and medical device industries [2] - Over the past 20 years, the company has collaborated with more than 3,600 partners, creating an innovative ecosystem that empowers the entire industry chain [2] - Tigermed has established over 180 offices and branches globally, employing more than 10,000 professionals across dozens of countries on five continents [2] - The company holds the highest MSCI ESG rating of AAA, a score of 60 on the S&P CSA ESG questionnaire, a B rating (management level) on the CDP climate change questionnaire, and maintains an AAA rating from the Shenzhen Stock Exchange National Index ESG [2] Compliance and Governance - Tigermed has built a compliance governance system covering the entire value chain, with a compliance and ESG committee under the board of directors, directly led by the director and general manager [3] - The company has established a systematic compliance risk management process, with specialized compliance groups regularly identifying, assessing, and responding to operational risks [3] - A multi-level supervision and risk identification mechanism is in place, covering headquarters, subsidiaries, and business departments, to ensure compliance and operational stability [3] Anti-Corruption and Data Security - The company has implemented a comprehensive anti-corruption and anti-bribery policy, with plans for company-wide anti-corruption training in 2024 [4] - Suppliers are required to sign a "Supplier Code of Conduct" and "Anti-Bribery and Anti-Corruption Commitment" during the onboarding process to ensure awareness of the company's policies [4] - Tigermed is continuously optimizing its data security management system, with measures to enhance network security, data lifecycle management, and information access control [4] - The company holds an ISO 27001:2013 information security management system certification, and three core business systems have passed the national information security level protection tier three certification [4] Intellectual Property Management - Tigermed views intellectual property as a crucial competitive advantage, having established various management policies and training programs related to intellectual property compliance [5] - The company is actively planning its intellectual property strategy and aims to achieve GB/T 29490-2023 intellectual property compliance management system certification in 2024 [5] Expert Commentary - In 2024, Tigermed will embed compliance objectives into executive assessments, with anti-corruption training covering all employees and 80% of global business (excluding listed subsidiaries) completing anti-corruption audits [5] - The requirement for suppliers to sign the "Anti-Bribery Commitment" ensures adherence to legal and ethical standards [5]